Divisability of diltiazem matrix sustained-release tablets

Pharmaceutical Development and Technology

Volumn 6, Issue 3, 2001, Pages 343-351

  Costa, P ^a   Sousa Lobo, J M ^a  

^a UNIVERSITY OF PORTO   (Portugal)

Author keywords

Diltiazem; Divisibility assay; Drug release; Drug release models; Tablets division

Indexed keywords

DILTIAZEM;

ARTICLE; DIFFUSION; DISSOLUTION; DRUG SOLUBILITY; MATRIX TABLET; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

ANALYSIS OF VARIANCE; CALCIUM CHANNEL BLOCKERS; CONFIDENCE INTERVALS; DELAYED-ACTION PREPARATIONS; DILTIAZEM; HYDROGEN-ION CONCENTRATION; MODELS, CHEMICAL; SOLUBILITY; TABLETS;

EID: 0034923485     PISSN: 10837450     EISSN: None     Source Type: Journal    
DOI: 10.1081/PDT-100002616     Document Type: Article

References (38)

1. Dissolution and bioavailability studies of whole and halved sustained release theophylline tablets
2. Analysis of in vitro dissolution of whole vs. half controlled-release theophylline tablets
3. Effect of tablet integrity on the dissolution rate of sustained-release preparations
4. Divisibility of sustained-release dosage-forms: Acetylsalicylic acid tablets
5. Drug release evaluation of diltiazem CR preparations
6. Effect of compaction pressure on the dissolution efficiency of some direct compression systems
7. The concept of dissolution efficiency
8. Rate of release of medicaments from ointment bases containing drugs in suspension
9. Mechanism of sustained-action medication. Theoretical analysis of rate of release of solid drugs dispersed in solid matrices
10. Influence of shape factors on kinetics of drug release from matrix tablets II: Experimental
11. Establishment of sink conditions in dissolution rate determinations - Theoretical considerations and application to nondisintegrating dosage forms
12. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules
13. Controlled release: Mechanisms and rates
14. Dependence of reaction velocity upon surface and agitation
15. Linearization of dissolution rate curves by the Weibull distribution
16. On methods of expressing dissolution rate data
17. Statistical optimisation of a controlled release formulation obtained by a double compression process: Application of a hadamard matrix and a factorial design
18. Dissolution of fludrocortisone from phospholipid coprecipitates
19. Mechanism of solute release from porous hydrophilic polymers
20. Analysis of fickian and non-fickian drug release from polymers
21. Drug/polymer matrix swelling and dissolution
22. Mathematical comparison of dissolution profiles
23. Bioequivalence
24. Rethinking the use of water as a dissolution medium
25. Some observations on rethinking the use of water as a dissolution medium
26. Uniformity of mass of single-dose preparations
27. Tablets divisibility test
28. Diltiazem hydrochloride extended-release capsules
29. Diltiazem hydrochloride tablets
30. Influence of stirring speed in the diltiazem hydrochloride release from tablets
31. Statistical issues on the FDA conjugated estrogen tablets bioequivalence guidance
32. Statistical evaluation of similarity factor (f2) as a criterion for assessment of similarity between dissolution profiles
33. In vitro dissolution profile comparison. Statistics and analysis of the similarity factor (f2)
34. Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets
35. On the assessment of similarity of drug dissolution profiles - A simulation study